Abstract

The use of phosphatidylcholines to directly stabilize cannabinoids within dry powder is described. Phosphatidylcholines include 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD). The dry powder containing the stabilized cannabinoids can be formulated for inhalation or oral delivery. Dry powder formulated for inhalation can include formyl diketopiperazine (FDKP). Oral delivery of the dry powder containing the stabilized cannabinoids includes delivery to the gastrointestinal tract and to the mucous membranes of the oral cavity.

IPC Classes  ?

• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Abstract

Various techniques for generating substantially homogenous mixtures of nonpolar materials and aqueous solutions are disclosed herein. An example method includes generating a substantially homogenous mixture of an aqueous solution and a nonpolar material by flowing the aqueous solution through a porous substrate infused with the nonpolar material.

IPC Classes  ?

• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• A61K 31/05 - Phenols
• A61K 31/60 - Salicylic acidDerivatives thereof
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/07 - Retinol compounds, e.g. vitamin A
• A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
• A61K 31/12 - Ketones
• A47J 31/06 - Filters or strainers for coffee or tea makers
• A47J 31/46 - Dispensing spouts, pumps, drain valves or like liquid transporting devices
• B65D 85/804 - Disposable containers or packages with contents which are infused or dissolved in situ
• A23F 5/26 - Extraction of water soluble constituents

Abstract

snsnsn-glycero-3-phosphocholine (DPPC) and cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD). The dry powder containing the stabilized cannabinoids can be formulated for inhalation or oral delivery. Dry powder formulated for inhalation can include formyl diketopiperazine (FDKP). Oral delivery of the dry powder containing the stabilized cannabinoids includes delivery to the gastrointestinal tract and to the mucous membranes of the oral cavity.

IPC Classes  ?

• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• A61K 36/185 - Magnoliopsida (dicotyledons)

Abstract

Various techniques for generating substantially homogenous mixtures of nonpolar materials and aqueous solutions are disclosed herein. An example method includes generating a substantially homogenous mixture of an aqueous solution and a nonpolar material by flowing the aqueous solution through a porous substrate infused with the nonpolar material.

IPC Classes  ?

• A47J 31/06 - Filters or strainers for coffee or tea makers
• A61J 1/00 - Containers specially adapted for medical or pharmaceutical purposes
• B65B 25/02 - Packaging agricultural or horticultural products
• B65B 29/06 - Packaging of substances to which a further ingredient, e.g. water, is to be added in the package by the user for mixing prior to dispensing

Abstract

NN-acylated fatty amino acids to reduce absorption variability in cannabinoid-based compositions.

IPC Classes  ?

• A61K 38/27 - Growth hormone [GH], i.e. somatotropin
• A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
• A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Goods & Services

(1) Medical instruments and devices, namely, inhalers for therapeutic use (1) Consulting services relating to integration engineering; information, advisory and consultancy services in the field of medical treatment services; information, advisory and consultancy services in the field of medical care and analysis services